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Abstract 
Background 
Dengue has been a notifiable disease in China since 1 September 1989. Cases have been 
reported each year during the past 25 years of dramatic socio-economic changes in China, 
and reached a historical high in 2014. This study describes the changing epidemiology of 
dengue in China during this period, to identify high-risk areas and seasons and to inform 
dengue prevention and control activities. 
Methods 
We describe the incidence and distribution of dengue in mainland China using notifiable 
surveillance data from 1990-2014, which includes classification of imported and indigenous 
cases from 2005-2014. 
Results 
From 1990-2014, 69,321 cases of dengue including 11 deaths were reported in mainland 
China, equating to 2.2 cases per one million residents. The highest number was recorded in 
2014 (47,056 cases). The number of provinces affected has increased, from a median of 
three provinces per year (range: 1 to 5 provinces) during 1990-2000 to a median of 14.5 
provinces per year (range: 5 to 26 provinces) during 2001-2014. During 2005-2014, 
imported cases were reported almost every month and 28 provinces (90.3%) were affected. 
However, 99.8% of indigenous cases occurred between July and November. The regions 
reporting indigenous cases have expanded from the coastal provinces of southern China and 
provinces adjacent to Southeast Asia to the central part of China. Dengue virus serotypes 1, 
2, 3, and 4 were all detected from 2009-2014. 
Conclusions 
In China, the area affected by dengue has expanded since 2000 and the incidence has 
increased steadily since 2012, for both imported and indigenous dengue. Surveillance and 
control strategies should be adjusted to account for these changes, and further research 
should explore the drivers of these trends. 
Please see related article: http://dx.doi.org/10.1186/s12916-015-0345-0 
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Background 
Dengue is an acute infectious disease caused by infection with any one of four serotypes of 
dengue virus (DENV 1-4), which are transmitted by Aedes mosquitoes [1]. There are an 
estimated 390 million dengue infections per year, of which 96 million manifest clinically 
(any level of disease severity) [2], among an estimated 2.5 to 4 billion people living in over 
100 countries where DENV transmission occurs [1-4]. More than 70% of people at risk 
reside in the Asia Pacific region, making this region the global epicenter of dengue activity 
[2,5,6]. Susceptibility to dengue in humans is universal. Recovery from infection with one 
serotype confers lifelong homologous immunity, but only short-term protection against other 
serotypes, and sequential infections put people at greater risk for severe illness [7-9]. Because 
no effective vaccine for dengue is currently available, the effective protective measures are 
those that suppress vector populations and prevent exposure to Aedes mosquito biting [1,10-
13]. 
In 1978 dengue fever reemerged in mainland China, in Foshan City of Guangdong province, 
after being absent for around 30 years [14]. Dengue became a notifiable disease on 1 
September 1989 in China, partly in response to outbreaks of dengue fever, with cases of 
dengue hemorrhagic fever being reported sequentially in Hainan, Guangxi, Fujian, Zhejiang, 
and Yunnan provinces during the 1980s. All of these provinces are located in the southeast 
coastal regions or around the national border with Myanmar, Laos, and Vietnam in Southeast 
Asia [15-17]. Here we describe the magnitude and distribution of dengue in mainland China 
based on the notifiable reporting data, focusing on seasonal and geographical patterns from 
1990 to 2014, and characteristics of imported and indigenous cases from 2005 to 2014, so as 
to identify high-risk areas and seasons and thereby help plan resource allocation for dengue 
prevention and control. 
Methods 
National dengue surveillance program 
On 1 September 1989, dengue was made statutorily notifiable in China. Dengue cases are 
diagnosed according to the unified diagnosis criteria issued by the Chinese Ministry of 
Health, including clinically diagnosed and laboratory confirmed cases (see next section) [18-
21]. All probable or laboratory confirmed cases are reported to the Chinese Center for 
Disease Control and Prevention (China CDC) in Beijing. Two datasets were used in this 
study. One includes dengue cases, aggregated by gender and 5-year age group, reported 
monthly between 1990 and 2004 by all provinces in mainland China, which includes 22 
provinces, four municipalities, and five autonomous regions. The other consists of individual 
dengue cases reported by doctors within 24 hours of diagnosis to the online National 
Notifiable Infectious Disease Reporting Information System at the China CDC from 2005 to 
2014. The individual data include gender, age, address, nationality, type of diagnosis, 
imported or indigenous case, serotype, hospitalization, date of illness onset, and various 
potential risk factors (see Additional file 1: Table S1). All the data used in this study were 
anonymized; the identity of any individual case cannot be uncovered. 
Case definition 
Three editions of criteria/guidelines for dengue diagnosis issued by the Chinese Ministry of 
Health in 1988, 2001, and 2008 were successively used from 1990 to 2014 (see Additional 
file 2: Table S2) [19-21]. Dengue cases are classified as probable or confirmed based on 
whether they are clinically diagnosed or laboratory confirmed. Probable cases are those 
diagnosed by local experienced physicians according to cases’ epidemiologic exposure and 
clinical manifestations; confirmed cases are clinically diagnosed cases for which any of the 
following laboratory results are reported by the local public health institutes: fourfold or 
greater increase in DENV-specific IgG antibody titer between paired samples, or positive 
DENV polymerase chain reaction (PCR) test, or positive virus isolation and identification 
[19-21]. Before 1 September 2008, a DENV-IgM positive laboratory result was classified as 
a confirmed case, but since then has been classified as probable. In the notifiable disease 
database, dengue cases are not reported with information about their disease severity, and 
classification as either a probable or confirmed case was not recorded before 2005. 
At the provincial level, an imported case of dengue is defined as a dengue case for which the 
patient had traveled to a dengue-affected foreign country or province of mainland China, and 
reported being bitten by mosquitoes within 15 days of the onset of illness [22,23]. In some 
cases, importation is defined based on laboratory results showing that the infecting dengue 
virus had a high sequence similarity in the preM/E region compared with viruses isolated 
from the putative source region where the patient had traveled [23]. Otherwise, a dengue case 
is considered to be an indigenous case. All imported cases in our datasets were classified as 
importations either from other countries or from other provinces. A determination about 
whether a case in the individual-level dataset from 2005 to 2014 was imported or indigenous 
was made by local public health institutes, following epidemiological investigations after a 
dengue case was diagnosed and reported by local physicians. 
Data analysis 
We included all cases with illness onset from 1 January 1990, to 31 December 2014 in the 
analysis. The crude incidence rate was estimated as the number of probable and confirmed 
cases divided by the population at each year-end, which was extracted from the China 
population and employment statistics yearbook 2013 of the National Bureau of Statistics of 
China. The population data in 2014 were estimated from the population data and growth rates 
in 2013. The epidemiologic characteristics of imported and indigenous cases in China from 
2005-2014 were also summarized. The Kruskal-Wallis test was used to examine whether the 
median age was significantly different between imported and indigenous cases, with a 
significance level of α = 0.05. 
To analyze the time series of dengue cases, we created heat maps of the proportion of cases 
reported in each month from 1990 to 2014 by province, standardized by the total number of 
cases in each province over the 25-year period, and ordered by latitude of capital city of each 
province (see Additional file 3: Figure S1 and Additional file 4: Table S3). To compare 
seasonal patterns of dengue by imported and indigenous cases, we also created heat maps of 
the mean value of the proportion of cases in each week from 2005 to 2014. Version 3.0.1 of 
the R statistical software (R Foundation for Statistical Computing, Vienna, Austria) [24] was 
used to produce the graphs and heat maps and conduct statistical analyses, and ArcGIS 10.0 
(ESRI, Redlands, CA, USA) was used to plot the geographical distribution of cases. 
Results 
Overall incidence 
During the 25-year period from 1990 to 2014, 69,321 cases of dengue including 11 deaths 
were reported to the national dengue surveillance system in China, with an average of 2.2 
cases per one million residents each year in mainland China. Annual case numbers displayed 
striking variations, with the highest recorded in 2014 (47,056 cases) and the lowest in 1992 
and 1996 (only two cases) (Figure 1). 
Figure 1 The incidence of dengue cases reported in mainland China, 1990-2014 (N = 
69,321). Panel A: The aggregated number of cases by year with the numbers of deaths in 
parentheses. Panel B: The morbidity of dengue per one million residents of mainland China 
at the end of each year. 
During 2005-2014, 55,114 cases including 7 deaths were reported, of which 2,061 (3.7%) 
were imported and 53,053 (95.3%) were indigenous (see Additional files 5, 6, and 7: Tables 
S4-S6). The annual incidence rate of imported cases was relatively stable, with a median of 
0.2 case per one million residents of affected provinces per year (IQR: 0.1-0.2 
cases/1,000,000), except for a slight increase in 2013 (0.4 case/1,000,000) and 2014 (0.5 
case/1,000,000) (Figure 2). Indigenous cases were reported each year from 2006 to 2014, 
with a median annual incidence of 2.5 cases per one million residents of affected provinces 
(IQR: 0.6-9.1 cases/1,000,000), decreasing from 2006 to 2011, and increasing from 2012 to 
2014 with a peak of 155.3 cases/1,000,000 and 6 deaths in 2014 (Figure 2 and see Additional 
file 8: Figure S2). 
Figure 2 The morbidity of imported (N = 2,061) and indigenous (N = 53,053) dengue cases 
by month per one million residents of affected provinces at the end of each year in mainland 
China, 2005-2014. 
Demographic and virologic features 
The overall male-to-female ratio was even from 1990 to 2014. However, there was a strong 
male predominance (2:1) among imported cases during 2005-2014 and an almost equal 
gender distribution for indigenous cases. The age distribution differed significantly between 
imported and indigenous cases during 2005-2014 (Kruskal-Wallis statistic = 228.3, df = 1, P 
< 0.001), with a younger median age of 32.5 years (IQR: 25.6-42.0) for imported cases and 
an older median age of 39.0 years (IQR: 26.3-53.7) for indigenous cases (Figure 3A and B, 
and see Additional file 9: Figure S3). 
Figure 3 The age and gender distribution and proportion of imported (N = 2,061) and 
indigenous (N = 53,053) dengue cases that were laboratory confirmed by year, 2005-2014. 
Panel A: The age distribution of male and female imported cases. Panel B: The age 
distribution of male and female indigenous cases. Panel C: The proportion of imported cases 
that were laboratory confirmed each year. Panel D: The proportion of indigenous cases that 
were laboratory confirmed each year. 
During 2005-2014, 75.8% (41,783/55,114) of reported dengue cases were laboratory 
confirmed; 84.7% (1,746/2,061) of imported cases and 75.5% (40,037/53,053) of indigenous 
cases. Of cases without laboratory confirmation, 89.4% were reported in 2014 (Figure 3C and 
D). Data on serotypes were only available for 415 (0.8%) indigenous cases during 2005-
2014: 362 (87.2%) cases with DENV-1 in Guangdong during 2011-2014, 40 (9.6%) DENV-2 
in Guangdong during 2013-2014, and 13 (3.1%) DENV-3 in Zhejiang in 2009 and 
Guangdong during 2012-2013. Among 18 (0.9%) imported cases with serotype data, all four 
serotypes were reported: DENV-1 (11 cases), DENV-2 (2), DENV-3 (3), and DENV-4 (2) 
during 2009-2014 (see Additional file 10: Figure S4). More demographic and epidemiologic 
results are shown in the Additional files. 
Geographical distribution 
The number of provinces reporting dengue cases has increased since 1990, from a median of 
3 provinces per year (range: 1 to 5 provinces) during 1990-2000 to a median of 14.5 
provinces per year (range: 5 to 26 provinces) during 2001-2014. The provinces affected have 
also expanded geographically from the southern to the northern parts of China (Figure 4A). 
During 2005-2014, except for Ningxia, Qinghai, and Tibet, all the other 28 provinces in 
mainland China had imported cases; the top provinces were Yunnan (28.8% of all imported 
cases), Guangdong (18.3%), Fujian (11.2%), Zhejiang (6.4%), and Hunan (5.4%) in southern 
China and the municipality of Beijing (4.4%) in northern China (Figure 4B and Figure 5). 
The suspected country of origin was recorded for 1,488 (81.5%) of all 1,826 dengue cases 
imported from other countries: 82.7% came from Southeast Asia, 8.3% from South Asia, and 
5.6% from Africa. There were 235 cases exported from four domestic provinces of mainland 
China to other provinces: Guangdong (96.2%), Yunnan (2.1%), Guangxi (1.3%), and Hainan 
(0.4%). Of those interprovincial case movements, most (96.6%) occurred in 2014. 
Figure 4 Heat map of dengue surveillance data by Chinese province, sorted by latitude of 
capital city, 1990-2014 (N = 69,321). On the Y-axis is listed the name of the province with 
the latitude of the capital city and a general classification of climate zone for each province. 
M: Mid-temperate; W: warm-temperate; C: cold; S: subtropical; T: tropical. A thumbnail 
map of all the provinces of China is provided at the end of the figure. Panel A: Time series of 
monthly dengue cases, 1990-2014, standardized by the number of total cases reported by 
each province. Panel B: Time series of monthly imported dengue cases, 2005-2014, 
standardized by the number of total cases reported by each province. Panel C: Time series of 
monthly indigenous dengue cases, 2005-2014, standardized by the number of total cases 
reported by each province. Panel D: Seasonal distribution of imported dengue cases, plotted 
as the mean value of the proportion of cases in each week of the year from 2005 to 2014. 
Panel E: Seasonal distribution of indigenous dengue cases, plotted as the mean value of the 
proportion of cases in each week of the year from 2005 to 2014. 
Figure 5 Years in which the first case of dengue was reported in each province in the time 
period of our dataset, 1990-2014. 
During 2005-2014, all 53,053 indigenous cases were limited to just seven provinces: 94.3% 
were reported in Guangdong from 2006 to 2014, 3.0% in Yunnan (3 years), 1.6% in Guangxi 
(2 years), 0.7% in Fujian (5 years), 0.4% in Zhejiang (2 years), 0.05% in Henan in 2013, and 
0.004% in Hainan in 2014. The affected regions expanded gradually over the 10-year period, 
from the coastal provinces (Hainan, Guangdong, Fujian, and Zhejiang) of southern China and 
provinces (Guangxi and Yunnan) adjacent to Southeast Asian countries to the central 
provinces of China (Henan) (Figures 4C, 5, 6 and see Additional file 11: Figure S5). 
Figure 6 The geographic distribution of dengue cases in mainland China, 2013 and 2014. 
Panel A: The distribution of dengue cases in 2013 (N = 4,779). Panel B: The distribution of 
dengue cases in 2014 (N = 47,056). 
Seasonality 
During 2005-2014, 74.5% of imported cases were reported between July and November with 
a peak in October (24.6%) (Figures 2 and 4D). Generally, there was a subpeak of imported 
cases before the epidemic of indigenous cases each year, with a median lag of 2 months 
(IQR: 1-3 months) from the peak of imported cases to the month of the first indigenous case 
onset. Except for one indigenous case that occurred in April of 2010 in Guangdong, no 
indigenous cases were reported from January to May during 2005-2014, and 99.8% of 
indigenous cases occurred in the July to November period, peaking in September (40.4%) 
and October (48.6%). However, indigenous cases in the provinces with higher latitudes 
(Henan, Zhejiang, and Fujian), which were limited in their warm season duration, showed 
earlier peaks and shorter epidemic periods than the provinces at lower latitudes, such as 
Guangdong and Yunnan (Figure 4E). 
Discussion 
In this study, a longitudinal surveillance dataset spanning 25 years in China was used to 
investigate changes in the epidemiological characteristics of imported and indigenous dengue 
during the period of dramatic social-economic changes that has occurred in China over the 
last three decades. We found that the geographic distribution of provinces affected by 
imported and indigenous dengue has expanded, especially since 2000, and recently the 
incidence rate of indigenous dengue has increased dramatically with a peak in the most recent 
recorded year. 
Magnitude and geographic extent of indigenous dengue 
The incidence of dengue in China during the period 1990-2014 was lower than the epidemics 
in 1980 and 1985-1986, which resulted in more than 600,000 cases with 475 deaths overall in 
Hainan [17,25]. However, since 1990, indigenous dengue has not been limited to Hainan and 
Guangdong provinces, but has spread gradually from southern coastal tropical or subtropical 
regions (Guangdong, Guangxi, Hainan) to the neighboring northern and western regions 
(Fujian, Zhejiang, and Yunnan), and even to the central part of China - Henan province with 
a generally warm climate (Figure 5) [15,16,26]. Compared to the major epidemic in the 
1980s, Hainan showed a dramatically decreased incidence of dengue with a few indigenous 
cases reported only in 1991 and 2014. Guangdong had the highest incidence of indigenous 
dengue over the last 25 years, with cases reported each year since 1997. Dengue transmission 
has also become evident in some previously unaffected areas, such as Ningbo city in the 
north of Zhejiang in 2004, Yiwu city in the inland part of Zhejiang in 2009, the central region 
of Henan province in 2013, and Nanping city in the central region of Fujian in 2014 [27-29]. 
This highlights the fact that the geographic range of dengue has apparently expanded in 
China, which is valuable information for consideration in national planning on dengue 
prevention and outbreak response. If dengue does continue to expand in China, this will need 
to be acknowledged in control planning, which currently focuses on Guangdong, Hainan, and 
Yunnan provinces in south China. 
However, the number of reported dengue cases might be influenced by the change of 
diagnosis criteria and case definitions, especially through the introduction of more sensitive 
and rapid laboratory tests between 1990 and 2014, which could result in an increased number 
of reported cases without increased transmission. Compared to the 1988 criteria, the 2001 
edition introduced the enzyme-linked immunosorbent assay (ELISA), immunofluorescence 
method, and dengue blot for serologic testing, RT-PCR for nucleic acid detection, and 
monoclonal antibody immunofluorescence for antigen detection. Then, the 2008 edition 
included MAC-ELISA for serologic testing and real-time fluorescence quantitative PCR for 
detecting nucleic acids, and classified a positive DENV-IgM result from a confirmed to a 
probable dengue case (See Additional file 2: Table S2) [19-21]. 
Demographic characteristics of imported and indigenous cases 
The age and gender distributions of imported and indigenous cases in China differ in a 
number of ways. Imported cases were younger than indigenous cases, and were more likely 
to be male. This may reflect a population of younger working male adults who tend to travel 
more domestically and regionally and thereby have more exposure risk to dengue. In 
addition, the indigenous cases occurred across all age groups, including the elderly, which is 
different from other countries in Southeast Asia where dengue is endemic and where most 
dengue cases occur in children or younger adults [30]. This pattern most likely is due to the 
fact that the population in China has very low seroprevalence of dengue antibodies, and is 
therefore broadly susceptible to dengue infection, whereas the population in dengue endemic 
countries has higher rates of immunity, especially in adults and the elderly [27,29,31]. 
However, the history of “mosquito bites” as part of the definition of imported case was 
impractical and likely introduced recall bias, which therefore probably underestimated the 
numbers and proportions of imported cases. A new guideline was issued in October 2014, 
which excludes “mosquitoes bite” in the definition of an imported case [23,32]. 
Dengue and Aedes mosquitoes 
Aedes albopictus has been found in nearly one third of China and is the most predominant 
species in south China except in Hainan province, which has both types of Aedes mosquitoes 
[16]. Aedes aegypti was implicated in outbreaks in Hainan in 1980 and 1985-1986 [17]. 
However, Ae. albopictus was the only vector species present in the outbreaks reported in 
Guangdong, Fujiang, and Zhejiang from 2004 to 2010 [27,33]. The importance of Ae. 
albopictus in dengue outbreaks appears to be increasing in China, which is worrisome 
because Ae. albopictus seems to adapt easily to new environments, even in a temperate 
climate, and to be associated with the huge population migration and urbanization in China 
and climatic change [16,34]. However, under a national sentinel vector surveillance project 
for dengue, only 16 counties out of 483 counties in the five provinces in south China 
conducted Aedes mosquito surveillance between June and October since 2005, and China did 
not have a national vector control program for dengue [19]. Therefore, it may be prudent for 
China to put more effort into mosquito surveillance and control for Ae. albopictus. 
Dengue virus serotypes 
In this study, we found all four serotypes of dengue virus in dengue patients in China, all of 
which are capable of causing dengue of any clinical severity [16,30]. DENV-3 was the first 
serotype documented in Guangdong in 1978 [14] and in Hainan in 1980 [25]. Then, in 2009 
and 2010, DENV-3 was isolated again in Guangdong from imported cases, but the 2010 
outbreak was not a reemergence of the 2009 strain [35]. DENV-3 was also isolated during the 
outbreak in Zhejiang in 2009, in Yunnan in 2013, including from severe cases, and in the first 
outbreak in central China in 2013 [28,29,36]. DENV-1 has become the predominant serotype 
since the 1990s [27,37]. During 2005-2011, DENV-1 was the predominant serotype in 
circulation in Guangdong, while all four serotypes have been identified in indigenous patients 
from different outbreak localities since 2009 [31,38]. In addition, after an absence of 20 years 
since the DENV-4 outbreak in 1990, DENV-4 was detected during the outbreak in 
Guangzhou in 2010, in a Guangzhou resident who traveled back from Thailand [39]. DENV-
2 was confirmed in Hainan in 1985-1986 [17], and a few cases were reported in 2013 and 
2014. The increasing diversity in DENV strains imported to China, especially in 2013 and 
2014, might increase the risk of DENV outbreaks and their severity in the near future, as well 
as the difficulty of dengue control. Therefore, monitoring this viral diversity should be 
considered in the design of surveillance and control strategies for China. 
Is dengue an endemic disease in China? Seasonality and virus source 
Because of the geographic and seasonal restriction of cases, dengue in mainland China is still 
characterized as an imported disease and is not recognized as endemic [40]. This 
characterization rests on the assumption that imported cases play a key role in initiating 
outbreaks in China [27,41]. From this study, we have shown that imported cases were 
reported in nearly every month during 2005 to 2014. However, indigenous cases were mainly 
reported from July to November, which indicates a strong seasonality to dengue transmission 
in China, with peak transmission occurring mostly in the hot and humid seasons. Two factors 
are likely to contribute to this pattern. Firstly, the large amount of rainfall from July to 
October increases the availability of breeding habitats of mosquitoes, thereby causing 
increases in mosquito population densities and the potential for dengue transmission [42]. 
Secondly, transmission intensity can also fluctuate with temperature due to concomitant 
fluctuations in the length of the incubation period in the mosquito or mosquito mortality or 
blood feeding rates [43-45]. 
The dengue case data presented here represent only the clinically apparent infections which 
presented to health care facilities. Previous studies have shown that a large and variable 
proportion of DENV infections are clinically inapparent or mildly symptomatic [46,47], 
though adults are more likely to experience symptomatic illness than children [48]. This 
suggests that there is likely a larger pool of DENV infections and cases in China than is 
represented in this dataset. However, the overall incidence likely remains low compared to 
that in neighboring endemic countries [49,50]. 
In addition, most of the first local dengue outbreaks in each city and year can be traced back 
to imported cases that sparked the outbreaks [27,33,39]. Although for some outbreaks initial 
imported cases cannot be identified [28,37], the molecular fingerprints of strains often 
suggest that the outbreak is likely due to viruses imported from other countries [37]. 
Molecular epidemiological analysis in the last three decades also did not identify any new 
variants of viruses that are unique to mainland China [16]. Although DENV-1 was 
predominant in most years in Guangzhou city during 2001-2010, the strains from each year 
belonged to different genotypes and none of them was found to be predominant, though 
Southeast Asian countries were generally found to be the most likely source [38]. This 
suggests that dengue in China is due to localized transmission sparked by regular virus 
importations from returned travelers or visitors, rather than endemic transmission. Therefore, 
more attention should be directed toward the early identification of imported cases from other 
countries, especially from Southeast Asia. 
Limitations 
There are some limitations in this study. Firstly, the data used were collected from passive 
public health surveillance. The data quality may be influenced by the key steps in 
surveillance including changing case definitions, reporting methods, availability of health 
facilities and laboratory diagnostics, under reporting, and completeness and accuracy of data 
over the years. Secondly, the individual case data were not reported before 2005, so 
demographic characteristics, laboratory confirmation, and the distribution of indigenous 
versus imported cases could only be analyzed from 2005-2014, and cases were not reported 
by the classification of disease severity. 
Challenge of dengue control in mainland China 
The expansion of global air travel and seaborne trade, and the huge population movements in 
China overcome geographic barriers for both disease vectors and pathogens, enabling them to 
move great distances in short periods of time [51-53]. With the rapid growth of the economy 
and urbanization in China, more and more people in China have moved away from their 
original residences, especially from central China to coastal provinces, and from poor rural 
areas to urban centers [54]. This migration changes epidemiological dynamics and 
environments and can promote the transmission of dengue virus, increasing the population at 
risk of infection, and creating major challenges for prevention and control. Further, the 
increasing labor movements in and out of China to dengue endemic countries all over the 
world are driving changes in imported dengue dynamics. 
The exceptionally high number of dengue cases in 2014 - a historical record since dengue 
became a notifiable disease in China in 1989 - serves as a reminder that even if dengue is not 
yet endemic in China, the possibility exists that the receptivity and vulnerability of certain 
areas to outbreaks could be increasing. Exploring the role of putative drivers of this huge 
outbreak, modeling and mapping the risk of importation and local transmission, and 
extracting lessons about how it could have been averted should be pursued immediately so as 
to inform future outbreak prediction and mitigation. 
Conclusions 
Based on notifiable surveillance data in mainland China from 1990-2014, the area affected by 
dengue has expanded since 2000 and the incidence has increased steadily since 2012, for both 
imported and indigenous dengue. Surveillance and control strategies should be adjusted to 
account for these changes, and further research should explore the drivers of these trends. 
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